United States · FDA National Drug Code directory
migraine relief
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 11822-0374_7b229f0e-7c5d-4c2e-8193-d626b953f429
- Product NDC
- 11822-0374
- Form
- TABLET, FILM COATED
- Composition / generic term
- Acetaminophen, Aspirin, Caffeine
- Labeler
- Rite Aid Corporation
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20020514 / 20261231
Source-listed ingredients
- ACETAMINOPHEN — 250 mg/1
- ASPIRIN — 250 mg/1
- CAFFEINE — 65 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (11822-0374-1) / 100 TABLET, FILM COATED in 1 BOTTLE · 11822-0374-1
- 1 BOTTLE in 1 CARTON (11822-0374-2) / 24 TABLET, FILM COATED in 1 BOTTLE · 11822-0374-2
- 1 BOTTLE in 1 CARTON (11822-0374-5) / 50 TABLET, FILM COATED in 1 BOTTLE · 11822-0374-5
- 1 BOTTLE in 1 CARTON (11822-0374-7) / 200 TABLET, FILM COATED in 1 BOTTLE · 11822-0374-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →